API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. KQ /
  3. 053030.KQ

BINEX Co. Ltd (053030 KQ) stock market data APIs

₩16840 580(3.6%) as of November 22, 2024
Price chart is built with Anychart

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd. has a co-development partnership with Genexine, Inc. to develop COVID-19 vaccine. The company was founded in 1957 and is based in Incheon, South Korea.

BINEX Co. Ltd Financial Data Overview

16260
16840
-
17000
16160
7710-27300
514 274 M
31 188 K
154 969 M
-382
0.6934
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '053030',
Type: 'Common Stock',
Name: 'BINEX Co. Ltd',
Exchange: 'KQ',
CurrencyCode: 'KRW',
CurrencyName: 'Korean Won',
CurrencySymbol: '₩',
CountryName: 'Korea',
CountryISO: 'KR',
OpenFigi: 'BBG000C1YHY1',
ISIN: 'KR7053030003',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Pharmaceuticals',
}

BINEX Co. Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 154 969 M
  • EBITDA 29 398 M
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get BINEX Co. Ltd Earnings via APIs

  • Latest Release 2024-11-12
  • EPS/Forecast -148.29

Get BINEX Co. Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get BINEX Co. Ltd latest news via APIs

TRIGR Therapeutics and Elpiscience Biopharmaceuticals Announce $117 Million Exclusive China Licensing Transaction for TR009, a Phase 1B Dual Angiogenic Bispecific Antibody Targeting DLL4/VEGF

- Transaction to immediately accelerate clinical development of TR009 in Greater China and combine with Elpiscience's deep pipeline of next generation immunotherapies - TRIGR and Elpiscience intend t...
  • BISPECIFIC ANTIBODIES
  • CANCER
  • CANCER IMMUNOTHERAPIES
  • CHIEF EXECUTIVE OFFICER
  • CLINICAL DEVELOPMENT
  • CLINICAL STAGE
  • ELPISCIENCE
  • ELPISCIENCE BIOPHARMACEUTICALS
  • GREATER CHINA
  • IMMUNOTHERAPIES
  • TRIGR

TRIGR Therapeutics and Elpiscience Biopharmaceuticals Announce $117 Million Exclusive China Licensing Transaction for TR009, a Phase 1B Dual Angiogenic Bispecific Antibody Targeting DLL4/VEGF

- Transaction to immediately accelerate clinical development of TR009 in Greater China and combine with Elpiscience's deep pipeline of next generation immunotherapies - TRIGR and Elpiscience intend t...
  • BISPECIFIC ANTIBODIES
  • CANCER
  • CANCER IMMUNOTHERAPIES
  • CHIEF EXECUTIVE OFFICER
  • CLINICAL DEVELOPMENT
  • CLINICAL STAGE
  • ELPISCIENCE
  • ELPISCIENCE BIOPHARMACEUTICALS
  • GREATER CHINA
  • IMMUNOTHERAPIES
  • TRIGR
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com